The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
NeoGenomics, Inc(NASDAQ:NEO) 
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates in two segments, Clinical Services and Pharma Services. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceuti...
Website: http://www.neogenomics.com
Founded: 2002
Full Time Employees: 1,700
CEO: Douglas M. Van Oort
Sector: Healthcare
Industry: Diagnostics & Research
NeoGenomics Number of Twitter Followers
NeoGenomics Days Payable Outstanding ttm (DPO)
NeoGenomics Days Receivable Outstanding ttm (DSO)
NeoGenomics Days Inventory Outstanding ttm (DIO)
NeoGenomics Op Cashflow Per Share ttm
NeoGenomics Free Cashflow Per Share ttm
NeoGenomics Cash Per Share ttm
NeoGenomics P/S ratio ttm
NeoGenomics (GAAP) P/E ratio ttm
NeoGenomics P/B ratio ttm
No extra charts and metrics for this ticker.